Скачать
Checkpoint Inhibitors for Newly Diagnosed Stage 4 NSCLC
Автор: OncLive
Загружено: 2018-02-28
Просмотров: 230
Описание:
Benjamin P. Levy, MD; Roy S. Herbst, MD, PhD; Hossain Borghaei, DO, MS; Naiyer A. Rizvi, MD; Suresh S. Ramalingam, MD; and Thomas E. Stinchcombe, MD, discuss the paradigm-changing clinical trial that led to the approval of pembrolizumab in the up-front setting of non–small cell lung cancer and practical considerations for use of immuno-oncology–based regimens in newly diagnosed patients.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
